Which of the follow ing drugs is contraindicated in a patient with raised intracranial pressure ?
**Core Concept**
Raised intracranial pressure (ICP) is a medical emergency requiring careful management to prevent further increase in ICP. Certain medications can exacerbate or mitigate this condition by affecting cerebral blood flow, vasodilation, or cerebrospinal fluid dynamics.
**Why the Correct Answer is Right**
The correct answer is a medication that can cause cerebral vasodilation, leading to an increase in cerebral blood flow and consequently ICP. This can be particularly harmful in patients with pre-existing raised ICP. For example, nitrates and hydralazine can cause vasodilation and potentially worsen ICP.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is not typically associated with significant vasodilation or increase in ICP.
**Option B:** This option is incorrect because it is often used to reduce ICP by causing vasoconstriction and decreasing cerebral blood flow.
**Option C:** This option is incorrect because it is not commonly used in the acute management of raised ICP and does not have a significant effect on cerebral blood flow or vasodilation.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that medications can have varying effects on ICP, and careful consideration should be given to the potential impact of any medication on a patient's intracranial pressure.
**Correct Answer: C. Hydralazine**